The NALP3 inflammasome is involved in the innate immune response to amyloid-β

Nature Immunology

Volumn 9, Issue 8, 2008, Pages 857-865

  Halle, Annett ^a   Hornung, Veit ^a   Petzold, Gabor C ^b   Stewart, Cameron R ^c   Monks, Brian G ^a   Reinheckel, Thomas ^d   Fitzgerald, Katherine A ^a   Latz, Eicke ^a   Moore, Kathryn J ^c   Golenbock, Douglas T ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CATHEPSIN B; CYTOPLASMIC RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN NALP3;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; IMMUNOPATHOGENESIS; INNATE IMMUNITY; LYSOSOME; MICROGLIA; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN SECRETION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CARRIER PROTEINS; IMMUNITY, NATURAL; INFLAMMATION; INFLAMMATION MEDIATORS;

EID: 47849085872     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1636     Document Type: Article

References (47)

1. Weiner, H.L. & Frenkel, D. Immunology and immunotherapy of Alzheimer's disease. Nat. Rev. Immunol. 6, 404-416 (2006).
2. Meyer-Luehmann, M. et al. Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer's disease. Nature 451, 720-724 (2008).
3. Simard, A.R., Soulet, D., Gowing, G., Julien, J.P. & Rivest S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49, 489-502 (2006).
4. Itagaki, S., McGeer, P.L., Akiyama, H., Zhu, S. & Selkoe, D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24, 173-182 (1989).
5. Weggen, S. et al. A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity. Nature 414, 212-216 (2001).
6. Schenk, D. et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400 173-177 (1999).
7. Akama, K.T. & Van Eldik, L.J. β-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1β- and tumor necrosis factor-α (TNFα)-dependent, and involves a TNFα receptor-associated factor- and NFκB-inducing kinase-dependent signaling mechanism. J. Biol. Chem. 275, 7918-7924 (2000).
8. Griffin, W.S. et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86, 7611-7615 (1989).
9. Blum-Degen, D. et al. Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 202, 17-20 (1995).
10. Dinarello, C.A. A signal for the caspase-1 inflammasome free of TLR. Immunity 26, 383-385 (2007).
11. Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241 (2006).
12. Mariathasan, S. et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232 (2006).
13. Dostert, C. et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674-677 (2008).
14. Amstad, P.A. et al. Detection of caspase activation in situ by fluorochrome-labeled caspase inhibitors. Biotechniques 31, 608-610 (2001).
15. Agostini, L. et al. NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20, 319-325 (2004).
16. Fernandes-Alnemri, T. et al. The pyroptosome: A supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ. 14, 1590-1604 (2007).
17. Liu, Y. et al. LPS receptor (CD14): A receptor for phagocytosis of Alzheimer's amyloid peptide. Brain 128, 1778-1789 (2005).
18. Mueller-Steiner, S. et al. Antiamyloidogenic and neuroprotective functions of cathepsin B: Implications for Alzheimer's disease. Neuron 51, 703-7 14 (2006).
19. Hook, V.Y., Kindy, M. & Hook, G. Inhibitors of cathepsin B Improve memory and reduce β-annyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, β-secretase site of the annyloid precursor protein. J. Biol. Chem. 283, 7745-7753 (2008).
20. Buttle, D.J., Murata, M., Knight, C.G. & Barrett, A.J. CA074 methyl ester: A proinhibitor for intracellular cathelpsin B. Arch. Biochem. Biophys. 299, 377-380 (1992).
21. Xie, Z. et al. Peroxynitrite mediates neurotoxicity of amyloid β-peptide1-42- and lipopolysaccharide-activated microglia. J. Neurosci. 22, 3484-3492 (2002).
22. Combs, C.K., Karlo, J.C., Kao, S.C. & Landreth, G.E. β-Amyloid stimulation of microglia and monocytes results in TNFα-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 21, 1179-1188 (2001).
23. Mariathasan, S. & Monack, D.M. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat. Rev. Immunol. 7, 31-40 (2007).
24. Li, M., Pisalyaput, K., Galvan, M. & Tenner, A.J. Macrophage colony stimulatory factor and interferon-γ trigger distinct mechanisms for augmentation of β-amyloid-induced microglia-mediated neurotoxicity. J. Neurochem. 91, 623-633 (2004).
25. El Khoury, J.B. et al. CD36 mediates the innate host response to β-amyloid. J. Exp. Med. 197, 1657-1666 (2003).
26. Weldon, D.T. et al. Fibrillar β-annyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J. Neurosci. 18, 2161-2173 (1998).
27. El Khoury, J. et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13, 432-438 (2007).
28. Kanneganti, T.D. et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440, 233-236 (2006).
29. Ishii, K.J., Coban, C. & Akira, S. Manifold mechanisms of Toll-like receptor-ligand recognition. J. Clin. Immunol. 25, 511-521 (2005).
30. Frackowiak, J. et al. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce β-amyloid fibrils. Acta Neuropathol. 84, 225-233 (1992).
31. Cataldo, A.M., Barnett, J.L., Pieroni, C. & Nixon, R.A. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: Neuropathologic evidence for a mechanism of increased β-amyloidogenesis. J. Neurosci. 17, 6142-6151 (1997).
32. Yang, A.J., Chandswangbhuvana, D., Margol, L. & Glabe, C.G. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Aβ1-42 pathogenesis. J. Neurosci. Res. 52, 691-698 (1998).
33. Kummer, J.A. et al. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J. Histochem. Cytochem. 55, 443-452 (2007).
34. Boraschi, D. & Tagliabue, A. The interleukin-1 receptor family. Vitam. Horm. 74, 229-254 (2006).
35. Shaftel, S.S. et al. Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J. Clin. Invest. 117, 1595-1604 (2007).
36. Richard, K.L., Filali, M., Prefontaine, P. & Rivest, S. Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid β 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J. Neurosci. 28, 5784-5793 (2008).
37. Tahara, K. et al. Role of toll-like receptor signalling in Aβ uptake and clearance. Brain 129, 3006-3019 (2006).
38. Franchi, L. et al. Cytosolic flagellin requires lpaf for activation of caspase-1 and interleukin 1β in salmonella-infected macrophages. Nat. Immunol. 7, 576-582 (2006).
39. Kuida, K. et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267, 2000-2003 (1995).
40. Halangk, W. et al. Role at cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J. Clin. Invest. 106, 773-781 (2000).
41. Moore, K.J. et al. A CD36-initiated signaling cascade mediates inflammatory effects of β-amyloid. J. Biol. Chem. 277, 47373-47379 (2002).
42. Severa, M., Coccia, E.M. & Fitzgerald, K.A. Toll-like receptor-dependent and -independent viperin gene expression and counter-regulation by PRDI-binding factor-1/BLIMP1. J. Biol. Chem. 281, 26188-26195 (2006).
43. Lehnardt, S. et al. A mechanism for neurodegenerartion induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia. J. Immunol. 177, 583-592 (2006).
44. Roberson, S.M. & Walker, W.S. Immortalization of cloned mouse splenic macrophages with a retrovirus containing the v-raf/mil and v-myc oncogenes. Cell. Immunol. 116, 341-351 (1988).
45. Blasi, E., Barluzzi, R., Bocchini, V., Mazzolla, R. & Bistoni, F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovinus. J. Neuroimmunol. 27, 229-237 (1990).
46. Lois, C., Hong, E.J., Pease, S., Brown, E.J. & Baltimore, D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295, 868-872 (2002).
47. Qi, Y., Wang, J.K., McMillian, M. & Chikaraishi, D.M. Characterization of a CNS cell tine CAD in which morphological differentiation is initiated by serum deprivation. J. Neurosci. 17, 1217-1225 (1997).